US Stocks
/
Citius Oncology, Inc. Share Price
Citius Oncology, Inc. Share Price

Citius Oncology, Inc. Share Price

NASDAQ: CTOR | Micro Cap
$1.03
+$0.08 (7.91%) Last updated on 18 Sep, 2026 | 00:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Citius Oncology, Inc. Stock Performance

Open
$1.01
Prev. Close
$0.96
Circuit Range
N/A
Day Range
$1.01 - $1.03
Year Range
$0.49 - $2.17
Volume
5,961
Average Traded
$1.03

Citius Oncology, Inc. Share Price Today

As of 18 September 2026, Citius Oncology, Inc.'s share price is $1.03. The stock opened at $1.01, compared to its previous close of $0.96. During today's trading session, Citius Oncology, Inc.'s share price traded between $1.01 and $1.03, with an average price of $1.02. Over the past 52 weeks, the stock has recorded a high of $2.17 and a low of $0.49. In terms of performance, Citius Oncology, Inc.'s share price has risen by 67.21% over the last six months and is down 48.25% on a year-on-year basis.

Citius Oncology, Inc. Share Price Chart

$1.01$1.03
L
Show Current Price
H

Citius Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$75.83M
PE Ratio (TTM)
-3.04
Dividend Yield
N/A
EPS (TTM)
$-0.34
Revenue (TTM)
N/A
Return On Equity (TTM)
-55.19%
Profit Margin
N/A
Debt to Equity
1.10
Quarterly Earnings Growth YoY
16.90%

Citius Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Dec 2024Mar 2025Jun 2025Dec 2025
RevenueN/AN/AN/AN/AN/A$3.94M
Net Profit$489829.00$252462.00-$6.66M-$7.74M-$5.37M-$5.53M
Net Profit MarginN/AN/AN/AN/AN/A-140.31%
Income ChangeN/A-48.46%-2737.71%-16.16%30.58%-3.06%

Citius Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars202220232025
RevenueN/AN/AN/A
Net Profit$380811.00$2.42M-$24.76M
Net Profit MarginN/AN/AN/A
Income ChangeN/A535.30%-1123.49%

About Citius Oncology, Inc.

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Citius Oncology, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$0.74
$1.03
+36.18%
Aug 2026
$0.68
$0.76
+37.18%
Jul 2026
$0.71
$0.55
-18.77%
Jun 2026
$0.79
$0.68
-15.80%
May 2026
$0.89
$0.81
-8.99%
Apr 2026
$0.61
$0.89
+43.78%
Mar 2026
$1.08
$0.62
-42.95%
Feb 2026
$1.04
$1.08
+0.46%
Jan 2026
$1.01
$1.08
+10.32%
Dec 2025
$1.48
$0.98
-27.48%
Nov 2025
$1.73
$1.35
-20.12%
Oct 2025
$1.99
$1.69
-15.50%

CTOR Share Price FAQs

What is Citius Oncology, Inc. share price today?

chevron-up
Citius Oncology, Inc. share price today is $1.03 as on September 18, 2026 at 12:25 am IST.

What is the 52 week high and 52 week low of Citius Oncology, Inc. stock?

chevron-up
The 52 week high of Citius Oncology, Inc. stock is $2.17, while the 52 week low is $0.49 as of 18 Sep '26.

What is CTOR's market capitalisation today?

chevron-up
CTOR market capitalisation is $75.83M as of September 18, 2026, at 1:39 pm IST.

What is CTOR's net income for the last quarter?

chevron-up
CTOR's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CTOR?

chevron-up
The 5 year returns of CTOR is -89.79% as on 18 Sep '26.

What is the high & low stock price of CTOR today?

chevron-up
CTOR stock price hit a high of $1.03 and low of $1.01 as of 18 Sep '26.

Can I buy CTOR shares in India?

chevron-up
Yes. You can buy CTOR in India by opening an international trading account.